4th Quarter - Report

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

Firm
Client
Income
—
Expenses
$970,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to prescription drug pricing and value Prescription drug manufacturing and supply chains Issues related to 340B program Issues related to tax Issues related to Intellectual Property Issues related to Inflation Reduction Act The Access to Prescription Digital Therapeutic Act of 2023 (S. 723/H.R. 1458)

LobbyistCovered position, as disclosed
KATHARINE TROLLER BOND —
CHRISTOPHER CUNNINGHAM New Snr Legis Assit Feb2021-Jun2022 SWild;Legis.Asst Jan.2019 Jan-2021 BMcAdamsUT04; LegisAssit Jan2018-Jan2019 EEsty CT05; Legis.Corresp Mar.2017-Jan.2018 EEstyCT05; StaffAssist Mar2016-Mar2017 MThompsonCA05; Intern Feb2016 -Mar2016 MThompsonCA05
SARAH ELIZABETH NORDSTROM —
MARY BRIDGET WALSH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1458 (118th), S. 723 (118th)

Medicare/Medicaid MMM

Issues related to Medicare Part D redesign Rebate reform Medicaid Drug Rebate Program (MDRP), including value-based purchasing (VBP) arrangements and line extensions Issues related to Biosimilars Issues regarding implementation of the Inflation Reduction Act Issues related to the Treat and Reduce Obesity Act (H.R. 4818/S.2407) The Access to Prescription Digital Therapeutic Act of 2023 (S. 723/H.R. 1458)

LobbyistCovered position, as disclosed
KATHARINE TROLLER BOND —
CHRISTOPHER CUNNINGHAM New Snr Legis Assit Feb2021-Jun2022 SWild;Legis.Asst Jan.2019 Jan-2021 BMcAdamsUT04; LegisAssit Jan2018-Jan2019 EEsty CT05; Legis.Corresp Mar.2017-Jan.2018 EEstyCT05; StaffAssist Mar2016-Mar2017 MThompsonCA05; Intern Feb2016 -Mar2016 MThompsonCA05
SARAH ELIZABETH NORDSTROM —
MARY BRIDGET WALSH —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 723 (118th), H.R. 4818 (118th), S. 2407 (118th), H.R. 1458 (118th)

Animals ANI

Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)

LobbyistCovered position, as disclosed
SCOTT BENNETT —
BILL DAVIS —
MARY BRIDGET WALSH —

Contacted: SENATE; Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES

Bills named: S. 1844 (118th), H.R. 1418 (118th), H.R. 3419 (118th), S. 1666 (118th)

Budget/Appropriations BUD

Issues related to FY2024 Appropriations

LobbyistCovered position, as disclosed
SCOTT BENNETT —
KATHARINE TROLLER BOND —
CHRISTOPHER CUNNINGHAM New Snr Legis Assit Feb2021-Jun2022 SWild;Legis.Asst Jan.2019 Jan-2021 BMcAdamsUT04; LegisAssit Jan2018-Jan2019 EEsty CT05; Legis.Corresp Mar.2017-Jan.2018 EEstyCT05; StaffAssist Mar2016-Mar2017 MThompsonCA05; Intern Feb2016 -Mar2016 MThompsonCA05
BILL DAVIS —
SARAH ELIZABETH NORDSTROM —
MARY BRIDGET WALSH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.